Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis.

Leclerc, Jacinthe

Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis. [electronic resource] - Circulation. Cardiovascular quality and outcomes Oct 2017

Publication Type: Comparative Study; Journal Article; Observational Study

1941-7705

10.1161/CIRCOUTCOMES.117.003891 doi


Angiotensin Receptor Antagonists--adverse effects
Antihypertensive Agents--adverse effects
Benzimidazoles--adverse effects
Biphenyl Compounds
Databases, Factual
Drug Costs
Drug Substitution--adverse effects
Drugs, Generic--adverse effects
Emergency Service, Hospital
Humans
Hypertension--diagnosis
Losartan--adverse effects
Patient Admission
Patient Safety
Population Surveillance
Quebec--epidemiology
Referral and Consultation
Retrospective Studies
Risk Factors
Tetrazoles--adverse effects
Therapeutic Equivalency
Time Factors
Treatment Outcome
Valsartan--adverse effects